Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03412604 · ClinicalTrials.gov registry record · NA
Effect of Modulating Gamma Oscillations Using tACS
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03412604: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03412604 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03412604, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study aims to implement an intervention based on multiple, individualized multifocal tACS stimulation sessions based on individual PET and MRI information in patients with amyloid-positive PET with the hope that this leads to microglia activation and decrease in cerebral amyloid and tau depositions in human patients with AD.
Interventions
- DEVICE Transcranial Alternating Current Stimulation (tACS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-08-02 |
| Est. Completion | 2019-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03412604
The ClinicalTrials.gov registry entry for NCT03412604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Alternating Current Stimulation (tACS) is the first listed.
NCT03412604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03412604 about?
NCT03412604 is a clinical study titled "Effect of Modulating Gamma Oscillations Using tACS". This study aims to implement an intervention based on multiple, individualized multifocal tACS stimulation sessions based on individual PET and MRI information in patients with amyloid-positive PET with the hope that this leads to microglia activation and decrease in cerebral amyloid and tau deposit...
What is the current status of trial NCT03412604?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-08-02. Estimated completion is 2019-09-15.
What interventions are being tested in trial NCT03412604?
The interventions under investigation include: Transcranial Alternating Current Stimulation (tACS) (DEVICE).
Who is sponsoring clinical trial NCT03412604?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.